Rapid Switch From Flolan to Remodulin in the Outpatient Clinic

Summary

The purpose of this 8-week study is to compare the effects of switching from therapy with epoprostenol or Flolan to IV Remodulin. This study will also assess the effect that changing to Remodulin will have on patient satisfaction with their treatment and impact on quality of life.

Timeline

Start

2008-03

Primary completion

2010-01

Completion

2012-02

Outcome

Outcome not reported

Stopped (Enrollment): “Due to availability of eligible subjects at center and enrollment competition with other studies.”

Drugs

Indications